Home
>
National Drug Code (NDC)
>
HYCAMTIN
HYCAMTIN - 0007-4205-11 - (topotecan hydrochloride)
Drug Information of HYCAMTIN
| Product NDC: | 0007-4205 |
| Proprietary Name: | HYCAMTIN |
| Non Proprietary Name: | topotecan hydrochloride |
| Active Ingredient(s): | .25 mg/1 & nbsp; topotecan hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of HYCAMTIN
| Product NDC: | 0007-4205 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020981 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080916 |
Package Information of HYCAMTIN
| Package NDC: | 0007-4205-11 |
| Package Description: | 10 CAPSULE in 1 BOTTLE (0007-4205-11) |
NDC Information of HYCAMTIN
| NDC Code | 0007-4205-11 |
| Proprietary Name | HYCAMTIN |
| Package Description | 10 CAPSULE in 1 BOTTLE (0007-4205-11) |
| Product NDC | 0007-4205 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | topotecan hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20080916 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Strength Number | .25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
